Investors who lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its competitive position and financial guidance during the specified class period [1]. Summary by Relevant Sections Allegations - The complaint claims that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is alleged that the company was reckless in raising its 2025 guidance without properly accounting for increasing customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business operations and prospects were materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of LifeMD during the specified timeframe are encouraged to register for the class action by October 25, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [2]. Firm's Commitment - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].